Intensive care medicine
-
Intensive care medicine · Jul 2021
Meta AnalysisIntegrative omics provide biological and clinical insights into acute respiratory distress syndrome.
Acute respiratory distress syndrome (ARDS) is accompanied by a dysfunctional immune-inflammatory response following lung injury, including during coronavirus disease 2019 (COVID-19). Limited causal biomarkers exist for ARDS development. We sought to identify novel genetic susceptibility targets for ARDS to focus further investigation on their biological mechanism and therapeutic potential. ⋯ Our findings suggest a novel susceptibility locus in ARDS pathophysiology that implicates BORCS5 and DUSP16 as potentially acting in immune-inflammatory processes. This locus warrants further investigation to inform the development of therapeutic targets and clinical care strategies for ARDS, including those induced by COVID-19.
-
Intensive care medicine · Jul 2021
Multicenter StudyPredictors of death and new disability after critical illness: a multicentre prospective cohort study.
This study aimed to determine the prevalence and predictors of death or new disability following critical illness. ⋯ Less than half of all patients mechanically ventilated for more than 24 h were alive and free of new disability at 6 months after admission to ICU. A model including age, illness severity and admission diagnosis has acceptable discriminative ability to predict death or new disability at 6 months.